Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AnaBio Technologies is an Irish biotechnology company specializing in advanced micro-encapsulation technologies for the food, beverage, and animal health sectors. The company develops patented delivery systems designed to protect sensitive bioactive ingredients—such as probiotics, vitamins, and amino acids—from environmental and digestive degradation. By ensuring targeted release in the gastrointestinal tract, AnaBio's solutions significantly enhance the bioavailability and shelf-stability of nutritional products. Headquartered in Cork, the firm operates as a specialized CDMO and R&D partner for global nutrition brands. In 2022, AnaBio was acquired by Kerry Group to bolster its portfolio of sustainable and functional nutritional technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anabio R&D.